{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:32:45Z","timestamp":1791819165925,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,12,8]],"date-time":"2005-12-08T00:00:00Z","timestamp":1134000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,12,8]],"date-time":"2005-12-08T00:00:00Z","timestamp":1134000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1038\/sj.leu.2404047","type":"journal-article","created":{"date-parts":[[2005,12,8]],"date-time":"2005-12-08T08:07:10Z","timestamp":1134029230000},"page":"254-263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring"],"prefix":"10.1038","volume":"20","author":[{"given":"L","family":"Boublikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kalinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"O'Marcaigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Stary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S R","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Trka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lawler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,12,8]]},"reference":[{"key":"BF2404047_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/BF02981935","volume":"73","author":"H Sugiyama","year":"2001","unstructured":"Sugiyama H . Wilms' tumor gene WT1: its oncogenic function and clinical application. Int J Hematol 2001; 73: 177\u2013187.","journal-title":"Int J Hematol"},{"key":"BF2404047_CR2","first-page":"223","volume":"68","author":"H Sugiyama","year":"2002","unstructured":"Sugiyama H . Wilms tumor gene WT1 as a tumor marker for leukemic blast cells and its role in leukemogenesis. Methods Mol Med 2002; 68: 223\u2013237.","journal-title":"Methods Mol Med"},{"key":"BF2404047_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0378-1119(01)00593-5","volume":"273","author":"V Scharnhorst","year":"2001","unstructured":"Scharnhorst V, van der Eb AJ, Jochemsen AG . WT1 proteins: functions in growth and differentiation. Gene 2001; 273: 141\u2013161.","journal-title":"Gene"},{"key":"BF2404047_CR4","first-page":"1060","volume":"9","author":"HD Menssen","year":"1995","unstructured":"Menssen HD, Renkl HJ, Rodeck U, Maurer J, Notter M, Schwartz S et al. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia 1995; 9: 1060\u20131067.","journal-title":"Leukemia"},{"key":"BF2404047_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF02982571","volume":"76","author":"HD Menssen","year":"2002","unstructured":"Menssen HD, Siehl JM, Thiel E . Wilms tumor gene (WT1) expression as a panleukemic marker. Int J Hematol 2002; 76: 103\u2013109.","journal-title":"Int J Hematol"},{"issue":"Part 9","key":"BF2404047_CR6","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1242\/jcs.00405","volume":"116","author":"KD Wagner","year":"2003","unstructured":"Wagner KD, Wagner N, Schedl A . The complex life of WT1. J Cell Sci 2003; 116 (Part 9): 1653\u20131658.","journal-title":"J Cell Sci"},{"key":"BF2404047_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/(SICI)1521-1878(199903)21:3<191::AID-BIES3>3.0.CO;2-8","volume":"21","author":"M Little","year":"1999","unstructured":"Little M, Holmes G, Walsh P . WT1: what has the last decade told us? Bioessays 1999; 21: 191\u2013202.","journal-title":"Bioessays"},{"key":"BF2404047_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0014-5793(99)00944-8","volume":"456","author":"K Moorwood","year":"1999","unstructured":"Moorwood K, Salpekar A, Ivins SM, Hall J, Powlesland RM, Brown KW et al. Transactivation of the WT1 antisense promoter is unique to the WT1[+\/\u2212] isoform. FEBS Lett 1999; 456: 131\u2013136.","journal-title":"FEBS Lett"},{"key":"BF2404047_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1006\/excr.2000.5131","volume":"264","author":"SB Lee","year":"2001","unstructured":"Lee SB, Haber DA . Wilms tumor and the WT1 gene. Exp Cell Res 2001; 264: 74\u201399.","journal-title":"Exp Cell Res"},{"key":"BF2404047_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/BF02982573","volume":"76","author":"DM Loeb","year":"2002","unstructured":"Loeb DM, Sukumar S . The role of WT1 in oncogenesis: tumor suppressor or oncogene? Int J Hematol 2002; 76: 117\u2013126.","journal-title":"Int J Hematol"},{"key":"BF2404047_CR11","doi-asserted-by":"publisher","first-page":"7562","DOI":"10.1073\/pnas.93.15.7562","volume":"93","author":"A Caricasole","year":"1996","unstructured":"Caricasole A, Duarte A, Larsson SH, Hastie ND, Little M, Holmes G et al. RNA binding by the Wilms tumor suppressor zinc finger proteins. Proc Natl Acad Sci USA 1996; 93: 7562\u20137566.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404047_CR12","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/oxfordjournals.hmg.a018914","volume":"9","author":"NA Little","year":"2000","unstructured":"Little NA, Hastie ND, Davies RC . Identification of WTAP, a novel Wilms' tumour 1-associating protein. Hum Mol Genet 2000; 9: 2231\u20132239.","journal-title":"Hum Mol Genet"},{"key":"BF2404047_CR13","first-page":"6615","volume":"62","author":"AL Menke","year":"2002","unstructured":"Menke AL, Clarke AR, Leitch A, Ijpenberg A, Williamson KA, Spraggon L et al. Genetic interactions between the Wilms' tumor 1 gene and the p53 gene. Cancer Res 2002; 62: 6615\u20136620.","journal-title":"Cancer Res"},{"key":"BF2404047_CR14","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/sj.leu.2402434","volume":"16","author":"T Karakas","year":"2002","unstructured":"Karakas T, Miething CC, Maurer U, Weidmann E, Ackermann H, Hoelzer D et al. The coexpression of the apoptosis-related genes bcl-2 and wt1 in predicting survival in adult acute myeloid leukemia. Leukemia 2002; 16: 846\u2013854.","journal-title":"Leukemia"},{"key":"BF2404047_CR15","doi-asserted-by":"publisher","first-page":"19627","DOI":"10.1074\/jbc.M201336200","volume":"277","author":"DM Loeb","year":"2002","unstructured":"Loeb DM, Korz D, Katsnelson M, Burwell EA, Friedman AD, Sukumar S . Cyclin E is a target of WT1 transcriptional repression. J Biol Chem 2002; 277: 19627\u201319632.","journal-title":"J Biol Chem"},{"key":"BF2404047_CR16","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1074\/jbc.M211606200","volume":"278","author":"G Idelman","year":"2003","unstructured":"Idelman G, Glaser T, Roberts Jr CT, Werner H . WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation. J Biol Chem 2003; 278: 3474\u20133482. E-pub 2002 Nov 19.","journal-title":"J Biol Chem"},{"key":"BF2404047_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1128\/MCB.24.2.537-549.2004","volume":"24","author":"B Carpenter","year":"2004","unstructured":"Carpenter B, Hill KJ, Charalambous M, Wagner KJ, Lahiri D, James DI et al. BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1. Regulation of the Wilms' tumour suppressor protein transcriptional activation domain. Mol Cell Biol 2004; 24: 537\u2013549.","journal-title":"Mol Cell Biol"},{"key":"BF2404047_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/hmg\/ddh040","volume":"13","author":"M Niksic","year":"2004","unstructured":"Niksic M, Slight J, Sanford JR, Caceres JF, Hastie ND . The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes. Hum Mol Genet 2004; 13: 463\u2013471. E-pub 2003 Dec 17.","journal-title":"Hum Mol Genet"},{"key":"BF2404047_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/hmg\/ddh038","volume":"13","author":"AR Dallosso","year":"2004","unstructured":"Dallosso AR, Hancock AL, Brown KW, Williams AC, Jackson S, Malik K . Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours. Hum Mol Genet 2004; 13: 405\u2013415. E-pub 2003 Dec 17.","journal-title":"Hum Mol Genet"},{"key":"BF2404047_CR20","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/emboj\/20.8.1897","volume":"20","author":"LW Ellisen","year":"2001","unstructured":"Ellisen LW, Carlesso N, Cheng T, Scadden DT, Haber DA . The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells. Embo J 2001; 20: 1897\u20131909.","journal-title":"Embo J"},{"key":"BF2404047_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1046\/j.1365-2141.2002.03261.x","volume":"116","author":"N Hosen","year":"2002","unstructured":"Hosen N, Sonoda Y, Oji Y, Kimura T, Minamiguchi H, Tamaki H et al. Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells. Br J Haematol 2002; 116: 409\u2013420.","journal-title":"Br J Haematol"},{"key":"BF2404047_CR22","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/sj.leu.2402906","volume":"17","author":"DM Loeb","year":"2003","unstructured":"Loeb DM, Summers JL, Burwell EA, Korz D, Friedman AD, Sukumar S . An isoform of the Wilms' tumor suppressor gene potentiates granulocytic differentiation. Leukemia 2003; 17: 965\u2013971.","journal-title":"Leukemia"},{"key":"BF2404047_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/10428199809050929","volume":"30","author":"H Sugiyama","year":"1998","unstructured":"Sugiyama H . Wilms tumor gene (WT1) as a new marker for the detection of minimal residual disease in leukemia. Leuk Lymphoma 1998; 30: 55\u201361.","journal-title":"Leuk Lymphoma"},{"key":"BF2404047_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3109\/10428199709039030","volume":"25","author":"L Bergmann","year":"1997","unstructured":"Bergmann L, Maurer U, Weidmann E . Wilms tumor gene expression in acute myeloid leukemias. Leuk Lymphoma 1997; 25: 435\u2013443.","journal-title":"Leuk Lymphoma"},{"key":"BF2404047_CR25","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood.V89.4.1405","volume":"89","author":"K Inoue","year":"1997","unstructured":"Inoue K, Ogawa H, Sonoda Y, Kimura T, Sakabe H, Oka Y et al. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood 1997; 89: 1405\u20131412.","journal-title":"Blood"},{"key":"BF2404047_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000040973","volume":"102","author":"E Niegemann","year":"1999","unstructured":"Niegemann E, Wehner S, Kornhuber B, Schwabe D, Ebener U . wt1 gene expression in childhood leukemias. Acta Haematol 1999; 102: 72\u201376.","journal-title":"Acta Haematol"},{"key":"BF2404047_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000041057","volume":"103","author":"U Ozgen","year":"2000","unstructured":"Ozgen U, Anak S, Ozbek U, Sarper N, Eryilmaz E, Agaoglu L et al. wt1 gene expression in childhood acute leukemias. Acta Haematol 2000; 103: 229\u2013230.","journal-title":"Acta Haematol"},{"key":"BF2404047_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF02981901","volume":"73","author":"Z Chen","year":"2001","unstructured":"Chen Z . The possible role and application of WT1 in human leukemia. Int J Hematol 2001; 73: 39\u201346.","journal-title":"Int J Hematol"},{"key":"BF2404047_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1046\/j.1365-2141.2001.02912.x","volume":"114","author":"KA Kreuzer","year":"2001","unstructured":"Kreuzer KA, Saborowski A, Lupberger J, Appelt C, Na IK, le Coutre P et al. Fluorescent 5\u2032-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias. Br J Haematol 2001; 114: 313\u2013318.","journal-title":"Br J Haematol"},{"key":"BF2404047_CR30","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1038\/sj.leu.2402675","volume":"16","author":"D Cilloni","year":"2002","unstructured":"Cilloni D, Gottardi E, De Micheli D, Serra A, Volpe G, Messa F et al. Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients. Leukemia 2002; 16: 2115\u20132121.","journal-title":"Leukemia"},{"key":"BF2404047_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000077562","volume":"112","author":"D Cilloni","year":"2004","unstructured":"Cilloni D, Saglio G . WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndrome. Acta Haematol 2004; 112: 79\u201384.","journal-title":"Acta Haematol"},{"key":"BF2404047_CR32","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/sj.leu.2402512","volume":"16","author":"J Trka","year":"2002","unstructured":"Trka J, Kalinova M, Hrusak O, Zuna J, Krejci O, Madzo J et al. Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry. Leukemia 2002; 16: 1381\u20131389.","journal-title":"Leukemia"},{"key":"BF2404047_CR33","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1182\/blood.V90.3.1217","volume":"90","author":"L Bergmann","year":"1997","unstructured":"Bergmann L, Miething C, Maurer U, Brieger J, Karakas T, Weidmann E et al. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 1997; 90: 1217\u20131225.","journal-title":"Blood"},{"key":"BF2404047_CR34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/sj.leu.2400620","volume":"11","author":"D Schmid","year":"1997","unstructured":"Schmid D, Heinze G, Linnerth B, Tisljar K, Kusec R, Geissler K et al. Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia. Leukemia 1997; 11: 639\u2013643.","journal-title":"Leukemia"},{"key":"BF2404047_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1600-0609.1999.tb01121.x","volume":"63","author":"A Gaiger","year":"1999","unstructured":"Gaiger A, Linnerth B, Mann G, Schmid D, Heinze G, Tisljar K et al. Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol. Eur J Haematol 1999; 63: 86\u201393.","journal-title":"Eur J Haematol"},{"key":"BF2404047_CR36","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1182\/blood.V97.7.2115","volume":"97","author":"JS Chen","year":"2001","unstructured":"Chen JS, Coustan-Smith E, Suzuki T, Neale GA, Mihara K, Pui CH et al. Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia. Blood 2001; 97: 2115\u20132120.","journal-title":"Blood"},{"key":"BF2404047_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10024-001-0208-x","volume":"5","author":"M Kletzel","year":"2002","unstructured":"Kletzel M, Olzewski M, Huang W, Chou PM . Utility of WT1 as a reliable tool for the detection of minimal residual disease in children with leukemia. Pediatr Dev Pathol 2002; 5: 269\u2013275.","journal-title":"Pediatr Dev Pathol"},{"key":"BF2404047_CR38","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/sj.bmt.1703380","volume":"29","author":"JM Siehl","year":"2002","unstructured":"Siehl JM, Thiel E, Leben R, Reinwald M, Knauf W, Menssen HD . Quantitative real-time RT-PCR detects elevated Wilms tumor gene (WT1) expression in autologous blood stem cell preparations (PBSCs) from acute myeloid leukemia (AML) patients indicating contamination with leukemic blasts. Bone Marrow Transplant 2002; 29: 379\u2013381.","journal-title":"Bone Marrow Transplant"},{"key":"BF2404047_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1046\/j.1365-2141.2003.04552.x","volume":"123","author":"M Garg","year":"2003","unstructured":"Garg M, Moore H, Tobal K, Liu Yin JA . Prognostic significance of quantitative analysis of WT1 gene transcripts by competitive reverse transcription polymerase chain reaction in acute leukaemia. Br J Haematol 2003; 123: 49\u201359.","journal-title":"Br J Haematol"},{"key":"BF2404047_CR40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/BF02983561","volume":"78","author":"H Tamaki","year":"2003","unstructured":"Tamaki H, Mishima M, Kawakami M, Tsuboi A, Kim EH, Hosen N et al. Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1). Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis. The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. Int J Hematol 2003; 78: 349\u2013356.","journal-title":"Int J Hematol"},{"key":"BF2404047_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/08880010390158568","volume":"20","author":"E Magyarosy","year":"2003","unstructured":"Magyarosy E, Varga N, Timar J, Raso E . Follow-up of minimal residual disease in acute childhood lymphoblastic leukemia by WT1 gene expression in the peripheral blood: the Hungarian experience. Pediatr Hematol Oncol 2003; 20: 65\u201374.","journal-title":"Pediatr Hematol Oncol"},{"key":"BF2404047_CR42","first-page":"926","volume":"89","author":"E Barragan","year":"2004","unstructured":"Barragan E, Cervera J, Bolufer P, Ballester S, Martin G, Fernandez P et al. Prognostic iplications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. Haematologica 2004; 89: 926\u2013933.","journal-title":"Haematologica"},{"key":"BF2404047_CR43","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/j.1365-2141.2004.04952.x","volume":"125","author":"M Ostergaard","year":"2004","unstructured":"Ostergaard M, Olesen LH, Hasle H, Kjeldsen E, Hokland P . WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients \u2013 results from a single-centre study. Br J Haematol 2004; 125: 590\u2013600.","journal-title":"Br J Haematol"},{"key":"BF2404047_CR44","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1182\/blood-2002-06-1831","volume":"101","author":"H Ogawa","year":"2003","unstructured":"Ogawa H, Tamaki H, Ikegame K, Soma T, Kawakami M, Tsuboi A et al. The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. Blood 2003; 101: 1698\u20131704.","journal-title":"Blood"},{"key":"BF2404047_CR45","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1046\/j.1365-2141.2003.04495.x","volume":"122","author":"M Uzunel","year":"2003","unstructured":"Uzunel M, Jaksch M, Mattsson J, Ringden O, Brune M, Johansson JE et al. Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia. Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation. Br J Haematol 2003; 122: 788\u2013794.","journal-title":"Br J Haematol"},{"key":"BF2404047_CR46","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/00043426-200306000-00006","volume":"25","author":"O Ramirez","year":"2003","unstructured":"Ramirez O, Linares A, Trujillo ML, Caminos JE . WT1 mRNA in cerebrospinal fluid associated with relapse in pediatric lymphoblastic leukemia. J Pediatr Hematol Oncol 2003; 25: 453\u2013458.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BF2404047_CR47","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/(SICI)1098-2264(199708)19:4<256::AID-GCC8>3.0.CO;2-W","volume":"19","author":"J Renshaw","year":"1997","unstructured":"Renshaw J, King-Underwood L, Pritchard-Jones K . Differential splicing of exon 5 of the Wilms tumour (WTI) gene. Genes Chromosomes Cancer 1997; 19: 256\u2013266.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF2404047_CR48","first-page":"31","volume":"31","author":"JM Siehl","year":"2004","unstructured":"Siehl JM, Reinwald M, Heufelder K, Menssen HD, Keilholz U, Thiel E et al. Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants. Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias. Ann Hematol 2004; 31: 31.","journal-title":"Ann Hematol"},{"key":"BF2404047_CR49","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1182\/blood.V99.9.3272","volume":"99","author":"OA Elisseeva","year":"2002","unstructured":"Elisseeva OA, Oka Y, Tsuboi A, Ogata K, Wu F, Kim EH et al. Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies. Blood 2002; 99: 3272\u20133279.","journal-title":"Blood"},{"key":"BF2404047_CR50","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1182\/blood-2002-01-0163","volume":"100","author":"C Scheibenbogen","year":"2002","unstructured":"Scheibenbogen C, Letsch A, Thiel E, Schmittel A, Mailaender V, Baerwolf S et al. CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia. Blood 2002; 100: 2132\u20132137.","journal-title":"Blood"},{"key":"BF2404047_CR51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF02982574","volume":"76","author":"H Sugiyama","year":"2002","unstructured":"Sugiyama H . Cancer immunotherapy targeting WT1 protein. Int J Hematol 2002; 76: 127\u2013132.","journal-title":"Int J Hematol"},{"key":"BF2404047_CR52","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/sj.leu.2402988","volume":"17","author":"C Rosenfeld","year":"2003","unstructured":"Rosenfeld C, Cheever MA, Gaiger A . WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies. Leukemia 2003; 17: 1301\u20131312.","journal-title":"Leukemia"},{"key":"BF2404047_CR53","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/BF02983241","volume":"78","author":"Y Oka","year":"2003","unstructured":"Oka Y, Tsuboi A, Murakami M, Hirai M, Tominaga N, Nakajima H et al. Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis. The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. Int J Hematol 2003; 78: 56\u201361.","journal-title":"Int J Hematol"},{"key":"BF2404047_CR54","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","volume":"17","author":"J Gabert","year":"2003","unstructured":"Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia \u2013 a Europe Against Cancer program. Leukemia 2003; 17: 2318\u20132357.","journal-title":"Leukemia"},{"key":"BF2404047_CR55","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","volume":"17","author":"E Beillard","year":"2003","unstructured":"Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u2018real-time\u2019 quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) \u2013 a Europe against cancer program. Leukemia 2003; 17: 2474\u20132486.","journal-title":"Leukemia"},{"key":"BF2404047_CR56","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","volume":"13","author":"JJ van Dongen","year":"1999","unstructured":"van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901\u20131928.","journal-title":"Leukemia"},{"key":"BF2404047_CR57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2141.1999.01365.x","volume":"105","author":"L Foroni","year":"1999","unstructured":"Foroni L, Harrison CJ, Hoffbrand AV, Potter MN . Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis. Br J Haematol 1999; 105: 7\u201324.","journal-title":"Br J Haematol"},{"key":"BF2404047_CR58","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1046\/j.1365-2141.2003.04393.x","volume":"121","author":"D Campana","year":"2003","unstructured":"Campana D . Determination of minimal residual disease in leukaemia patients. Br J Haematol 2003; 121: 823\u2013838.","journal-title":"Br J Haematol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404047","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T15:17:59Z","timestamp":1706800679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,8]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2,1]]}},"alternative-id":["BF2404047"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404047","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,8]]},"assertion":[{"value":"29 June 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2005","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}